Cambridge Investment Research Advisors
ORTX

Cambridge Investment Research Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,230
Closed -$307K – 2512
2019
Q4 		$307K Buy
+2,230
New +$271K ﹤0.01% 1899

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cambridge Investment Research Advisors's ORTX Position: Q1 2020 in Review

Cambridge Investment Research Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2020, closing a stake of 2,230 shares — an estimated $307K sold.

Cambridge Investment Research Advisors first reported a position in ORTX in Q4 2019 and held it in 1 quarter. The position peaked at $307K in Q4 2019. 74 funds tracked by Wall St. Rank hold ORTX as of Q1 2020.

  • Cambridge Investment Research Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 2,230 Orchard Therapeutics plc American Depositary Shares shares in Q1 2020, an estimated $307K.
  • Cambridge Investment Research Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $307K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2020, filed 8 May 2020.